Details for New Drug Application (NDA): 201049
✉ Email this page to a colleague
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE is glimepiride; pioglitazone hydrochloride. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glimepiride; pioglitazone hydrochloride profile page.
Summary for 201049
Tradename: | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE |
Applicant: | Sandoz |
Ingredient: | glimepiride; pioglitazone hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 201049
Mechanism of Action | Peroxisome Proliferator-activated Receptor Activity |
Suppliers and Packaging for NDA: 201049
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE | glimepiride; pioglitazone hydrochloride | TABLET;ORAL | 201049 | ANDA | Sandoz Inc | 0781-5634 | 0781-5634-10 | 1000 TABLET in 1 BOTTLE (0781-5634-10) |
PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE | glimepiride; pioglitazone hydrochloride | TABLET;ORAL | 201049 | ANDA | Sandoz Inc | 0781-5634 | 0781-5634-31 | 30 TABLET in 1 BOTTLE (0781-5634-31) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG;30MG | ||||
Approval Date: | Jan 4, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 4MG;30MG | ||||
Approval Date: | Jan 4, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription